A weight-loss dietary supplement called OxyElite Pro has been linked to a rash of hepatitis cases in Hawaii. The Hawaii Department of Health is currently investigating 29 cases of acute hepatitis. At least 24 of the patients reported using OxyElite Pro. Eleven people have been hospitalized, two required liver transplants, and one person has died so far.
Dr. Sarah Park, an epidemiologist for the State of Hawaii, stated that OxyElite Pro is the only supplement or medication that more thank two patients had in common. The patients were tested for viral hepatitis, but none had a viral infection.
In April 2013, the U.S. Food and Drug Administration warned consumers of potentially serious health risks associated with products containing dimethylamylamine (DMAA), including OxyElite Pro. USPLabs, the Dallas-based distributor of OxyElite Pro, issued a statement that the "original version with DMAA has not been manufactured or distributed since early 2013."
USPLabs has halted distribution of OxyElite Pro in the United States, pending an investigation.